The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global New Drug Modeling Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Database
1.2.3 Software
1.2.4 Others
1.3 Market by Application
1.3.1 Global New Drug Modeling Solution Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Discovery and Development
1.3.3 Computational Physiological Medicine
1.3.4 Disease Modeling
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global New Drug Modeling Solution Market Perspective (2018-2029)
2.2 New Drug Modeling Solution Growth Trends by Region
2.2.1 Global New Drug Modeling Solution Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 New Drug Modeling Solution Historic Market Size by Region (2018-2023)
2.2.3 New Drug Modeling Solution Forecasted Market Size by Region (2024-2029)
2.3 New Drug Modeling Solution Market Dynamics
2.3.1 New Drug Modeling Solution Industry Trends
2.3.2 New Drug Modeling Solution Market Drivers
2.3.3 New Drug Modeling Solution Market Challenges
2.3.4 New Drug Modeling Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top New Drug Modeling Solution Players by Revenue
3.1.1 Global Top New Drug Modeling Solution Players by Revenue (2018-2023)
3.1.2 Global New Drug Modeling Solution Revenue Market Share by Players (2018-2023)
3.2 Global New Drug Modeling Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by New Drug Modeling Solution Revenue
3.4 Global New Drug Modeling Solution Market Concentration Ratio
3.4.1 Global New Drug Modeling Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New Drug Modeling Solution Revenue in 2022
3.5 New Drug Modeling Solution Key Players Head office and Area Served
3.6 Key Players New Drug Modeling Solution Product Solution and Service
3.7 Date of Enter into New Drug Modeling Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 New Drug Modeling Solution Breakdown Data by Type
4.1 Global New Drug Modeling Solution Historic Market Size by Type (2018-2023)
4.2 Global New Drug Modeling Solution Forecasted Market Size by Type (2024-2029)
5 New Drug Modeling Solution Breakdown Data by Application
5.1 Global New Drug Modeling Solution Historic Market Size by Application (2018-2023)
5.2 Global New Drug Modeling Solution Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America New Drug Modeling Solution Market Size (2018-2029)
6.2 North America New Drug Modeling Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America New Drug Modeling Solution Market Size by Country (2018-2023)
6.4 North America New Drug Modeling Solution Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe New Drug Modeling Solution Market Size (2018-2029)
7.2 Europe New Drug Modeling Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe New Drug Modeling Solution Market Size by Country (2018-2023)
7.4 Europe New Drug Modeling Solution Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific New Drug Modeling Solution Market Size (2018-2029)
8.2 Asia-Pacific New Drug Modeling Solution Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific New Drug Modeling Solution Market Size by Region (2018-2023)
8.4 Asia-Pacific New Drug Modeling Solution Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America New Drug Modeling Solution Market Size (2018-2029)
9.2 Latin America New Drug Modeling Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America New Drug Modeling Solution Market Size by Country (2018-2023)
9.4 Latin America New Drug Modeling Solution Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa New Drug Modeling Solution Market Size (2018-2029)
10.2 Middle East & Africa New Drug Modeling Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa New Drug Modeling Solution Market Size by Country (2018-2023)
10.4 Middle East & Africa New Drug Modeling Solution Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 JSR Corporation(Crown Bioscience)
11.1.1 JSR Corporation(Crown Bioscience) Company Detail
11.1.2 JSR Corporation(Crown Bioscience) Business Overview
11.1.3 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Introduction
11.1.4 JSR Corporation(Crown Bioscience) Revenue in New Drug Modeling Solution Business (2018-2023)
11.1.5 JSR Corporation(Crown Bioscience) Recent Development
11.2 Chemical Computing Group ULC
11.2.1 Chemical Computing Group ULC Company Detail
11.2.2 Chemical Computing Group ULC Business Overview
11.2.3 Chemical Computing Group ULC New Drug Modeling Solution Introduction
11.2.4 Chemical Computing Group ULC Revenue in New Drug Modeling Solution Business (2018-2023)
11.2.5 Chemical Computing Group ULC Recent Development
11.3 Nimbus Therapeutics
11.3.1 Nimbus Therapeutics Company Detail
11.3.2 Nimbus Therapeutics Business Overview
11.3.3 Nimbus Therapeutics New Drug Modeling Solution Introduction
11.3.4 Nimbus Therapeutics Revenue in New Drug Modeling Solution Business (2018-2023)
11.3.5 Nimbus Therapeutics Recent Development
11.4 schrodinger, Inc
11.4.1 schrodinger, Inc Company Detail
11.4.2 schrodinger, Inc Business Overview
11.4.3 schrodinger, Inc New Drug Modeling Solution Introduction
11.4.4 schrodinger, Inc Revenue in New Drug Modeling Solution Business (2018-2023)
11.4.5 schrodinger, Inc Recent Development
11.5 Genedata AG
11.5.1 Genedata AG Company Detail
11.5.2 Genedata AG Business Overview
11.5.3 Genedata AG New Drug Modeling Solution Introduction
11.5.4 Genedata AG Revenue in New Drug Modeling Solution Business (2018-2023)
11.5.5 Genedata AG Recent Development
11.6 Biognos AB
11.6.1 Biognos AB Company Detail
11.6.2 Biognos AB Business Overview
11.6.3 Biognos AB New Drug Modeling Solution Introduction
11.6.4 Biognos AB Revenue in New Drug Modeling Solution Business (2018-2023)
11.6.5 Biognos AB Recent Development
11.7 Compugen Ltd
11.7.1 Compugen Ltd Company Detail
11.7.2 Compugen Ltd Business Overview
11.7.3 Compugen Ltd New Drug Modeling Solution Introduction
11.7.4 Compugen Ltd Revenue in New Drug Modeling Solution Business (2018-2023)
11.7.5 Compugen Ltd Recent Development
11.8 Dassault Systemes
11.8.1 Dassault Systemes Company Detail
11.8.2 Dassault Systemes Business Overview
11.8.3 Dassault Systemes New Drug Modeling Solution Introduction
11.8.4 Dassault Systemes Revenue in New Drug Modeling Solution Business (2018-2023)
11.8.5 Dassault Systemes Recent Development
11.9 Acellera
11.9.1 Acellera Company Detail
11.9.2 Acellera Business Overview
11.9.3 Acellera New Drug Modeling Solution Introduction
11.9.4 Acellera Revenue in New Drug Modeling Solution Business (2018-2023)
11.9.5 Acellera Recent Development
11.10 lnstem(Leadscope)
11.10.1 lnstem(Leadscope) Company Detail
11.10.2 lnstem(Leadscope) Business Overview
11.10.3 lnstem(Leadscope) New Drug Modeling Solution Introduction
11.10.4 lnstem(Leadscope) Revenue in New Drug Modeling Solution Business (2018-2023)
11.10.5 lnstem(Leadscope) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details